Is Pharma Right About the Need for a COVID-19 Booster Shot?
The intrinsic role of real-world data to help determine the necessity for booster shots as new...
Understanding re-identification risk in PPRL: key takeaways from our expert webinar
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches...
HealthVerity IPGE and the challenges with real-world data
In a recent HealthVerity LIVE webinar, we took an in-depth look at how the HealthVerity IPGE...
Can real-world data enrich clinical trials?
COVID-19 urgently highlighted the need for real-time data, and with it, the need to tap into a...
The key to longitudinal patient journeys
A data-rich longitudinal patient journey is key to research and development, commercialization and...
The modern way to data: An executive conversation with AWS
This post was originally published on the AWS for Industries blog by Jared Saul, Global Head of ...
How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
How Longitudinal Patient Insights Transform Clinical Trials
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
2021 data imperatives: The pulse of the industry
The healthcare industry relies on real-world data more and more to make informed and effective...
HVPCI reports positive swing to patient confidence
December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
HVPCI drops due to COVID-19 restrictions and telehealth fatigue
November 24, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...